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Abstract
Background: Residents of Massachusetts and Rhode Island were exposed to tetrachloroethylene-contaminated
drinking water from 1968 through the early 1990s when it leached from the vinyl lining of asbestos cement water
distribution pipes. While occupational exposure to solvents during pregnancy has consistently been linked to an
increased risk of certain birth defects, mixed results have been observed for environmental sources of exposure,
including contaminated drinking water. The present case-control study was undertaken to examine further the
association between prenatal exposure to tetrachloroethylene-contaminated drinking water and the risk of central
nervous system defects, oral clefts and hypospadias.
Methods: Cases were comprised of live- and stillborn infants delivered between 1968 and 1995 to mothers who
resided in 28 Massachusetts and Rhode Island cities and towns with some PCE-contaminated water supplies. Infants
with central nervous system defects (N = 268), oral clefts (N = 112) and hypospadias (N = 94) were included. Controls
were randomly selected live-born, non-malformed infants who were delivered during the same period and geographic
area as cases (N = 771). Vital records and self-administered questionnaires were used to gather identifying information,
birth defect diagnoses, and other relevant data. PCE exposure during the first trimester was estimated using water
distribution system modeling software that incorporated a leaching and transport model. Prenatal PCE exposure was
dichotomized as “high” or “low” exposure at the level corresponding to an estimated average concentration of 40 μg/
L, the criterion for remediation when PCE contamination was discovered in 1980.
Results: Mothers with “high” levels of exposure to PCE-contaminated drinking water during the first trimester (> 40 μg/
L) had increased odds of having a child with spina bifida (OR: 2.0, 95% CI: 0.8–5.4), cleft lip with or without cleft palate
(OR: 3.8, 95% CI: 1.2–12.3) and hypospadias (OR: 2.1, 95% CI:0.5–8.3). No increases in the odds of other defects were
observed in relation to “high” exposure levels.
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Conclusions: The results of the present study suggest that mothers with “high” PCE exposure levels during the first
trimester have increased odds of having a child with spina bifida, cleft lip with or without cleft palate, and hypospadias.
These findings support several prior studies that observed an increased risk of selected birth defects following prenatal
exposure to solvents in occupational and environmental settings. Even though PCE contamination from vinyl lined
pipes was remediated many years ago, it remains a widespread contaminant across the U.S and so environmental
regulations must be guided by a precautionary perspective that safeguards pregnant women and their offspring.
Keywords: Tetrachloroethylene, Drinking water, Birth defects
Background
Tetrachloroethylene (PCE) is a commercially important
solvent used in dry cleaning, textile processing, and metal
degreasing [1]. Because most of its use occurs in poorly
controlled workplaces such as dry cleaning businesses and
garages, PCE is a frequent contaminant of public drinking
water supplies in the United States [2, 3]. The most recent
sampling survey from the U.S. Geological Survey found
PCE in 7% of surface water samples and 24% of ground-
water samples [3].
While improper waste disposal is the typical source of
PCE-contaminated drinking water, the public drinking
water supplies in New England were affected when PCE
leached from the vinyl lining (VL) of asbestos cement
(AC) water distribution pipes. The liner, which was ap-
plied to the interior of the pipe in a slurry of vinyl toluene
resin and PCE, had been introduced in 1968 in response
to complaints about water’s taste and odor [4]. Pipes were
dried for 48 h before shipping assuming that most of the
PCE would evaporate by the time the pipes were installed
[5]. Yet, more than a decade lapsed before it was discov-
ered that large quantities of PCE remained in the liner
and leached into the public drinking water supplies.
Officials in Massachusetts (MA) and Rhode Island (RI)
determined that approximately 750 miles of VLAC pipes
had been installed in about 100 cities and towns in the
two states [4]. Because the lined pipes were used to re-
place existing pipe and extend the water system as the
population grew, neighboring streets had different con-
taminant levels.
Levels in MA water monitoring samples taken in 1980
ranged from 1.5 to 80 μg/l in medium and high flow lo-
cations and 1600 to 7750 μg/l in low flow locations [5].
RI samples from eleven systems had levels that exceeded
the 1980 EPA suggested no adverse response level
(SNARL) of 40 μg/L [6]. Remediation to bring water
levels below the SNARL was subsequently initiated by
bleeding and flushing the pipes [5]. The maximum con-
taminant level is currently 5 μg/l and reported levels in
MA and RI are now below this level [7, 8].
PCE’s neurotoxic and carcinogenic effects have been
well-established [1, 9]. There is also evidence of adverse
effects on birth outcomes, including congenital anomalies.
Animal experiments suggest that prenatal exposure to
PCE and trichloroethylene (TCE) increase the risk of
anomalies (e.g., [10, 11]). Several epidemiological studies
have also reported associations between occupational ex-
posure to organic solvents during pregnancy and congeni-
tal anomalies [12–19]; however, the literature examining
women with community exposure to contaminated air
and drinking water has conflicting findings [20–28].
Our prior retrospective cohort study in Cape Cod,
MA found that women with any prenatal PCE exposure
had infants with a 3.1-fold increased risk of central ner-
vous system defects (95% CI: 0.9–11.0), a 3.5-fold in-
creased risk of neural tube defects (95% CI: 0.8–14.0), a
3.2-fold increased risk of oral clefts (95% CI: 0.7–15.0),
and a 1.4-fold increased risk of hypospadias (95% CI:
0.4–5.4) [20]. Because these findings were based on a
small number of cases identified via maternal reports,
we undertook present case-control study to examine fur-
ther the association between PCE-contaminated drink-
ing water and the risk of birth defects with a larger
number of cases identified through vital records.
Methods
Selection of study population
Cases were comprised of live- and stillborn infants who
were delivered from 1968 through 1995 to residents of
24 MA and four RI cities and towns with some VLAC
water distribution pipes. Approximately 480 miles of
VLAC pipes were installed in these towns, representing
approximately 63% of the VLAC pipes in the two states.
The remaining RI and MA towns with VLAC pipes were
excluded from the present study because they had few
VLAC pipes, lacked documentation on the locations and
dates of VLAC pipe installation, and/or small resident
populations. Available water sampling data indicated
that PCE contamination persisted in public water sup-
plies of selected towns through the 1990s because the
target level for remediation was 40 μg/L [7].
Cases were identified by abstracting birth defect diag-
noses from livebirth, fetal death, and death certificate re-
cords (N = 479). Based on associations observed in our
prior cohort study [20], infants with the following de-
fects were selected: central nervous system defects
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(CNS) (including anencephaly, spina bifida with or with-
out hydrocephalus, encephalocele, hydrocephalus alone,
microcephaly and other CNS defects), oral clefts (cleft lip
with and without cleft palate and cleft palate alone), and
hypospadias. Cases with more than one birth defect were
eligible for inclusion; however, those with recognized syn-
dromes were excluded. Prenatal testing followed by elect-
ive termination of affected pregnancies was uncommon
during the case ascertainment period [29, 30].
Controls were randomly selected from livebirth records
of non-malformed infants born during the same period to
residents of the same geographic area as the cases. The
control selection process was stratified by state and birth
year so that the number of controls selected from MA
and RI was proportional to their number of births over
the ascertainment period (45% from RI and 55% from
MA). A total of 800 controls were targeted for selection;
794 remained after excluding duplicate subjects.
Questionnaire and vital record data collection
Paper copies of livebirth, fetal death and death certifi-
cates and computerized vital record data were abstracted
to obtain parent’s and infant’s names; maternal address
at delivery; infant’s date of birth; maternal age, race, and
educational level; paternal age and educational level; ma-
ternal pregnancy history; date of last menstrual period;
prenatal care information and birth defect diagnoses.
Mothers were subsequently traced and sent self-admin-
istered questionnaires. Overall, 4.2% of case mothers (N =
20) and 7.2% of control mothers (N = 57) were found to
be deceased. We successfully located 87.4 and 88.3% of
living case (N = 401) and control mothers (N = 651), re-
spectively, and, of these, 38.6% of case mothers (N = 155)
and 31.8% of control mothers (N = 207) returned the
questionnaire after two mail and one telephone reminder.
The purpose of the questionnaire was to identify mothers
who moved during pregnancy and augment vital records
data on birth defect diagnoses and confounding variables.
When we compared the demographic characteristics
of questionnaire respondents and non-respondents, we
found that the two groups were similar with respect to
PCE exposure status (68.5% of case respondents versus
68.0% of case non-respondents and 66.2% of control re-
spondents versus 70.7% of control non-respondents) and
delivery year (e.g., 28.9% of case respondents versus 26.7%
of case non-respondents and 37.4% of control respondents
versus 37.7% of control non-respondents delivered during
1968–1978). While respondents were more likely to reside
in Massachusetts (77.2% of case respondents versus 66.8%
of case non-respondents and 72.8% of control respondents
versus 51.0% of control non-respondents), be older at de-
livery (median age was 29.0 for case respondents versus
26.7 for case non-respondents and 28.3 for control re-
spondents versus 26.6 for control non-respondents), and
begin prenatal care in the first trimester (93.9% of case re-
spondents versus 85.3% of case non-respondents and
90.8% of control respondents versus 86.3% of control
non-respondents), these differences were present for both
case and control mothers who returned our study
questionnaire.
Geocoding of residential addresses
Residential addresses at birth recorded in vital records
were geocoded to a latitude and longitude using ArcGIS
(10.0, ESRI, Redlands, CA). First trimester addresses of
questionnaire respondents who moved during pregnancy
were also geocoded (N = 33 cases and 33 controls).
Whenever possible, each address was assigned to a par-
cel of land. Addresses that could not be geocoded to a
parcel were geocoded to the closest parcel address by
street number. If a street number was unavailable, the
address was geocoded to the middle of the street when
the street was less than a mile long or to the intersection
of the address with the cross-street when the street was
a mile or longer. Overall 98.7% of the addresses were
successfully geocoded. All geocoding was conducted
without knowledge of case-control status.
PCE exposure assessment
Because historical water sampling data for PCE was
scant, we estimated each subject’s prenatal exposure
used a leaching and transport model. The model was de-
veloped for our research by Webler and Brown [31, 32]
to estimate the mass of PCE entering the drinking water
using the starting quantity of PCE in the pipe liner, the
pipe’s age, the leaching rate of PCE from the liner into
the water, and the water flow rate through the pipe. The
initial amount of PCE in the liner was based on the pipe
dimensions and information from the manufacturer on
the application of the liner. The leaching rate of PCE
was determined in experiments by Demond [5].
We incorporated the Webler Brown algorithm into
the open source code of EPANET, water distribution sys-
tem modeling software created by the US EPA [33]. Ini-
tially designed to investigate water quality problems,
EPANET has been used in several epidemiological stud-
ies investigating adverse health effects of drinking water
contaminants (e.g. [34]). The combined modeling ap-
proach integrated pipe schematics, water use, and PCE
transport to determine the water flow rate and direction
and the amount of PCE at points of consumption
throughout the distribution system.
GIS maps of geocoded residences and the water distribu-
tion systems were used to construct a graphic for each
town depicting the locations and characteristics of the pipes
(e.g. VLAC or not) and consumption points. We assigned
each mother’s residence to the closest consumption point
on the distribution system. The model simulation estimated
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the average mass of PCE in grams delivered to each sub-
ject’s residence during the calendar year when the first tri-
mester ended. We estimated the annual exposure because
we did not have data on the month of move-in or VLAC
pipe installation. Average monthly exposure was obtained
by dividing annual exposures by 12. Questionnaire respon-
dents who report using a private well for their prenatal
water supply (N = 21) were considered unexposed.
Data analysis
The strength of the association between PCE exposure
and each birth defect was estimated with odds ratios
(OR) and statistical stability was evaluated with 95%
confidence intervals. The following defect groups were
examined: any central nervous system defect, any neural
tube defect, any anencephaly, any spina bifida (with and
without hydrocephalus), any other CNS defects, any oral
cleft, any cleft lip (with or without cleft palate), cleft pal-
ate alone, and hypospadias. Cases with more than one of
these defects contributed to each subgroup. Analyses of
hypospadias were limited to male cases and controls.
ORs were calculated only if there were at least three ex-
posed cases and three exposed controls.
Analyses first compared mothers who were ever ex-
posed to PCE-contaminated drinking water during the
calendar year the first trimester ended to unexposed
mothers. We focused on exposure during the first tri-
mester because the structural defects under study form
during this period [35]. Next, we dichotomized PCE ex-
posure at 1.136 g, the level corresponding to an average
monthly drinking water concentration of 40 μg/L during
the calendar year that the first trimester ended. This
concentration was the criterion for remediation when
PCE contamination was discovered in 1980. Levels
above 40 μg/L were designated as “high.” Each set of
analyses was repeated after (1) incorporating exposure
levels at the first trimester address for questionnaire re-
spondents who moved during pregnancy, (2) excluding
cases and controls with a family history of defects, (3)
excluding cases with multiple defects, and (4) excluding
cases included in our prior cohort study (N = 10).
Logistic regression models estimated ORs while con-
trolling for confounding variables. We selected potential
confounders from those available in the vital records
and self-administered questionnaires based on a litera-
ture review and construction of directed acyclic graphs.
Multiple imputation was used to obtain values of poten-
tial confounders with missing data. The amount of miss-
ing data ranged from 0% (state of residence and delivery
year) to 72.5% (maternal alcoholic beverage consump-
tion). Variables with a high proportion of missing data
came solely from the self-administered questionnaires.
Twenty imputed data sets were generated using the fully
conditional specification (FCS) multiple imputation
method based on 27 variables. Point and variance esti-
mates from the imputed data sets were subsequently
combined and used in adjusted analyses.
Initial adjusted models controlled for one potential
confounder at a time. Controlling for delivery year had
the greatest impact on the crude associations and so it
was included in all multivariate models. We also decided
to include state in all multivariable models to account
for variations in case ascertainment between the two
states. Additional variables that changed the crude asso-
ciation between PCE exposure and each type of birth de-
fect by > = 10% were also included in the final models;
these included maternal alcoholic beverage consumption
in the oral cleft analyses and maternal race in the hypo-
spadias analyses.
Results
The final analysis was based on 268 cases with CNS mal-
formations (including 151 neural tube defects and 117
other CNS defects), 112 cases with oral clefts (including
59 with cleft lip with or without cleft palate and 53 with
cleft palate alone), 94 cases with hypospadias, and 771
controls. These numbers include 10 cases identified
through the maternal questionnaire: 7 cases of hypospa-
dias, 1 case of spina bifida and 2 cases of cleft lip with
cleft palate. In addition, these numbers exclude 5 cases
and 11 controls whose residential information was insuf-
ficient for geocoding, 12 controls whose questionnaire
data indicated the presence of a congenital anomaly
(that was not recorded in state records), and 12 cases
whose questionnaire data indicated that the defect was
part of a syndrome (also omitted from state records).
Overall, 68.3% of CNS cases, 72.3% of oral cleft cases,
61.7% of hypospadias cases and 67.8% of control mothers
had some PCE exposure during the first trimester. The ex-
posure distributions of cases and controls spanned several
orders of magnitude (Table 1). There were no discernable
trends in the exposure distribution of cases versus con-
trols, except at the upper end of the distribution where
higher exposure levels were observed among cases.
Both case and control mothers were predominantly
white but, depending on the case group, differed on
many other demographic and behavioral characteristics,
such as state of birth, delivery year, maternal educational
level and prenatal cigarette smoking (Table 2).
Any PCE exposure during the first trimester was not
associated with meaningful increases in the adjusted
odds of all CNS defects combined, neural tube defects,
anencephaly, spina bifida, other CNS defect or hypospa-
dias (Table 3). In contrast, any first trimester PCE expos-
ure was associated with a 2.1-fold increase in the
adjusted odds of cleft lip with or without cleft palate
(95% CI: 1.1–4.0) that rose to 3.8 for prenatal PCE ex-
posure levels above 40μg/L (95% CI: 1.2–12.3) (p value
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for trend 0.13). “High” PCE exposure levels were also as-
sociated with increases in the adjusted odds of spina
bifida with and without hydrocephalus (OR: 2.0, 95% CI:
0.8–5.4) and hypospadias (OR: 2.1, 95% CI: 0.5–8.3). No
increases in the odds of other CNS defects were ob-
served in relation to “high” PCE exposure levels. Only
one case of cleft palate alone was exposed to “high” PCE
exposure levels and so we did not estimate its associated
odds ratio; any PCE exposure was associated with a
1.4-fold increase in the adjusted odds of cleft palate
alone (95% CI: 0.7–2.7).
No meaningful changes in these results were observed
when the analysis incorporated exposure levels at the first
trimester address for questionnaire respondents who
moved during pregnancy or excluded cases and controls
with a family history of defects, cases with multiple de-
fects, or cases in our prior cohort study (data not shown).
Discussion
The results of the present study suggest that pregnant
women exposed to “high” levels of PCE-contaminated
drinking water during the first trimester have an in-
creased odds of spina bifida, cleft lip with or without
cleft palate and hypospadias. No evidence of increases in
the odds of other defects were observed in relation to
“high” exposure levels.
Several limitations should be considered when interpret-
ing these results. First, these findings are statistically un-
stable and have wide confidence intervals because a small
number of mothers were exposed to PCE levels above the
remediation cut point. Second, even though results from a
prior validation study indicate good correlation between our
modeled exposure estimates and PCE concentrations in his-
torical water samples from Cape Cod (Spearman correlation
coefficient (ρ) = 0.65, p < 0.00010 [36], non-differential ex-
posure misclassification stemming from our model-based
exposure estimates likely attenuated the observed associa-
tions. In addition, our leaching and transport model did not
estimate personal exposure levels but rather the mass of
PCE delivered to the home. Behavioral data on prenatal
water consumption and bathing habits during 1969–1995
were available only for questionnaire respondents and con-
sidered poor quality because of the long recall period. Thus,
it was not incorporated into our analysis.
Still another limitation arose from using vital records
to identify birth defect cases and non-malformed con-
trols because this source of information was likely to
suffer from mis-reporting and under-reporting. Direct
evidence for these inaccuracies comes from the ques-
tionnaire data where mothers reported 12 syndromes
that had been recorded as single defects in vital records
and 22 defect diagnoses that were not recorded in vital
records. Indirect evidence comes from birth defects sur-
veillance data in Massachusetts and Rhode Island that
suggest the number of cases identified (with the possible
exception of anencephaly) was lower than expected
when multiple sources of case ascertainment are used
[37, 38]. However, even though there was a great deal of
publicity when the contamination was discovered in 1980,
possible carcinogenic effects were the focus of concern in
newspaper reports (e.g., [39]), and so there is no reason to
believe that recording of defects in vital records was re-
lated to PCE exposure. There is also no reason to believe
that reporting of defects on the questionnaire was related
to PCE exposure since only 2% of exposed mothers
thought that their drinking water was contaminated with
PCE. Thus, these errors were likely non-differential
thereby biasing the results towards the null.
Because VLAC pipes were used to replace existing
pipes and expand the distribution system in response to
the growing population, the geographic pattern of con-
tamination was irregular. In fact, depending on the dir-
ection of water flow, neighboring homes could have very
different exposure levels. Thus, despite several different
characteristics among cases and controls, little con-
founding was observed in the analysis likely from the
lack of associations between PCE exposure and potential
confounders. Multiple imputation procedures were used
fill in missing values on confounders. While they are
considered the most valid approach for handing this
problem [40], we cannot rule out the possibility that re-
sidual confounding affected the results.
Selection bias was unlikely because we were unaware of
the exposure status when we selected cases and controls
for study. Despite the low questionnaire response rate and
the numerous demographic differences between respon-
dents and non-respondents, these differences were present
for both cases and controls and so were unlikely sources
of bias. Moreover, analyses were conducted on the entire
sample, irrespective of respondent status.
Table 1 Distribution of Average Monthly PCE Exposure (g)
During Year First Trimester Ended Among All Exposed Case and
Control Mothers
Exposed Exposed
Case Mothers Control Mothers
Minimum 5.2 × 10− 7 2.1 × 10− 8
5th Percentile 2.1 × 10− 5 2.2 × 10− 5
10th Percentile 7.7 × 10− 5 5.4 × 10− 5
25th Percentile 4.4 × 10− 4 6.8 × 10− 4
Median 3.4 × 10− 3 5.9 × 10− 3
75th Percentile 3.9 × 10− 2 5.6 × 10− 2
90th Percentile 5.0 × 10− 1 4.3 × 10− 1
95th Percentile 1.8 1.2
Maximum 24.8 81.81
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Table 2 Distribution of selected characteristics of cases and controls
Characteristic CNS Cases (N = 268) Oral Clef Cases (N = 112) Hypospadias Cases (N = 94) All Controls (N = 771)
n % n % n % n %
Maternal residence at delivery
Massachusetts 167 62.3 85 75.9 81 86.2 436 56.5
Rhode Island 101 37.7 27 24.1 13 13.8 335 43.5
Infant year of birth
1969–1978 98 36.6 20 17.9 14 14.9 275 35.7
1979–1988 88 32.8 45 40.2 27 28.7 290 37.6
1989–1995 82 30.6 47 42.0 53 56.4 206 26.7
Infant gender
Male 131 49.4 65 58.0 94 100 408 52.9
Female 134 50.6 47 42.0 – – 363 47.1
Missing 3
Maternal age at delivery (mean, sd) 26.3 (6.1) 27.8 (5.3) 29.3 (5.2) 27.0 (5.4)
Missing 3 0 0 0
Paternal age at delivery (mean, sd) 29.3 (6.3) 30.8 (5.8) 31.7 (6.2) 29.8 (6.1)
Missing 30 11 0 34
Maternal race
White 201 90.5 94 92.2 86 96.6 613 90.1
Non-White 21 9.5 8 7.8 3 3.4 67 9.9
Missing 46 10 5 91
Maternal educational level
< High school 36 16.7 10 9.9 7 7.9 96 14.3
High school graduate 104 48.1 42 41.6 26 29.2 244 36.4
Some college 36 16.7 32 31.7 26 29.2 172 25.7
College graduate 40 18.5 17 16.8 30 33.7 158 23.6
Missing 52 11 5 101
Prenatal care began in first trimester
Yes 162 84.4 89 89.9 85 97.7 473 87.9
No 30 15.6 10 10.1 2 2.2 65 12.1
Missing 76 13 7 233
Prenatal cigarette smoking
Yes 29 21.8 21 31.8 12 15.6 70 24.3
No 104 78.2 45 68.2 65 84.4 218 75.7
Missing 135 46 17 483
Prenatal alcoholic beverage consumption
Yes 19 23.8 19 51.4 9 29.0 69 35.6
No 61 76.3 18 48.6 22 71.0 125 64.4
Missing 188 75 63 577
Number of prior livebirths
0 91 41.4 38 37.3 43 47.8 296 43.8
1 68 30.9 36 35.3 28 31.1 217 32.1
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Because we investigated defect diagnoses at birth, it is
possible that a differential loss of pregnancies before this
point may have led us to underestimate the true effect of
PCE exposure. Such a ‘competing mortality’ bias could
exist if the pregnancies most susceptible to PCE-induced
birth defects were not included in our study because
they were more likely to be spontaneously aborted earl-
ier in pregnancy. Previous findings from our prior re-
search, however, suggest that prenatal PCE exposure is
not associated with early pregnancy loss [41].
Numerous animal experiments have found an adverse
effect of prenatal exposure to PCE, the closely related
solvent trichloroethylene (TCE), and their metabolite
trichloroacetic acid (TCA) on the risk of congenital de-
fects. An increased prevalence of cardiovascular, muscu-
loskeletal, central nervous system and ocular anomalies
have been observed among chicks and rats over a wide
range of prenatal exposure levels (e.g., [10, 11]).
Many epidemiological studies have also found positive
associations between occupational exposure to organic
solvents during pregnancy and the risk of congenital
anomalies, including oral clefts, neural tube defects and
cardiac defects [12–14, 18, 19, 42]. However, these studies
are difficult to interpret because broad exposure categories
including many different solvents were typically examined.
Studies of dry cleaning workers with only PCE exposure
were too small to provide meaningful results [43–46].
A smaller body of literature examining women ex-
posed via contaminated air and drinking water has less
consistent results with several studies reporting increases
in the risk of birth defects associated with PCE and/or
TCE exposure [20–26] while others reporting null find-
ings [24, 27, 28].
Differing results have also been observed for drinking
water studies that examined the defects included in our
investigation. A 1986 study of well water contaminated
with TCE (267 ppb), PCE (21 ppb), and other compounds
in Woburn, MA found an increased prevalence of central
nervous system, oral cleft and chromosomal defects com-
bined among children with prenatal exposure [23]. While
a follow-up study also found that Woburn residents had a
higher prevalence of certain defects, including neural tube
defects, cleft lip, hypospadias and chonal atresia [27, 47],
investigators attributed this to differences in case ascer-
tainment between Woburn and the comparison popula-
tion [27]. The similar frequency of defects before and after
the affected wells were closed also led investigators to
conclude that their occurrence was not associated with
prenatal exposure to contaminated well water.
In contrast, a 1995 New Jersey study found that PCE
drinking water levels > 10 ppb were associated with a
3.5-fold increased risk of oral clefts (90% CI: 1.3–8.8), TCE
drinking water levels > 5 ppb were associated with a 2.2 fold
increased risk of oral clefts (90% CI: 1.2–4.2), and TCE
levels > 10 ppb were associated with a 2.5-fold increased
risk of neural tube defects (90% CI: 0.9–6.4) [22]. Positive
associations were also observed between any prenatal ex-
posure to PCE-contaminated drinking water and the risk of
neural tube defects (OR: 3.2, 95% CI: 0.9–11.0), and oral
clefts (OR: 3.0, 95% CI: 0.7–13.0), and hypospadias (OR: 1.4,
95% CI: 0.4–5.4) in our previous study of births from Cape
Cod MA [20]. Lastly, a study from Marine Corps Base
Camp Lejeune found a 2.4-fold increased odds of neural
tube defects in relation to TCE exposure levels > 5 ppb
(95% CI: 0.6–9.6) but no associations between neural tube
defects and oral clefts and any level of PCE exposure [24].
The two studies using different metrics for airborne
solvent exposure also have conflicting results for the de-
fects examined in the present investigation. A study
using broadly categorized census-tract estimates of TCE
levels reported a 2.0-fold increased odds of spina bifida
for medium exposure levels (0.5–.16 μg/m3) (95% CI:
1.1–3.6) and a 1.3-fold increased odds for high exposure
levels (> 0.16 μg/m3) (95% CI: 0.6–2.8) [25] while a study
using a highly refined emission weighted residential
proximity model found no associations between PCE
and TCE and either neural tube defects or oral clefts
(PCE ORs and 95% CI: 0.92, 0.81–1.06 and 0.98, 0.88–
1.08, respectively, and TCE ORs and 95% CI: 0.95, 0.83–
1.09 and 1.02, 0.92–1.13, respectively) [28].
Possible explanations for differing results among the en-
vironmental studies include small numbers of defect cases
leading to unstable results, exposure misclassification, in-
adequate control of confounding, as well as differences in
Table 2 Distribution of selected characteristics of cases and controls (Continued)
Characteristic CNS Cases (N = 268) Oral Clef Cases (N = 112) Hypospadias Cases (N = 94) All Controls (N = 771)
n % n % n % n %
2+ 61 27.7 28 27.5 19 21.1 163 24.1
Missing 48 10 4 95
Possible maternal exposure to solvents in workplacea
Yes 2 2.5 5 13.9 1 3.1 4 2.1
No 79 97.5 31 86.1 31 96.9 185 97.9
Missing 187 76 62 582
aAscertained from a series of questions on jobs and job activities that typically involve solvent exposure (e.g., metal degreasing)
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Table 3 Frequencies, Odds Ratios and 95% Confidence Intervals for Birth Defects According to Average Monthly PCE Exposure
during Year First Trimester Ended
Number of Cases Number of Controls Crude Odds Ratio (95% CI) Multivariablea Odds Ratio (95% CI)
All Central Nervous System Defects (N = 268)
Any Exposure 183 523 1.0 (0.8–1.4) 1.1 (0.8–1.6)
No Exposure 85 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 13 32 1.2 (0.6–2.4) 1.2 (0.6–2.4)
> 0- < =1.136 g 170 491 1.0 (0.7–1.4) 1.1 (0.8–1.6)
0 (Referent) 85 248 1.0 (−-----)
P value for trend 0.64
All Neural Tube Defects (N = 151)
Any Exposure 100 523 0.9 (0.6–1.3) 1.1 (0.8–1.7)
No Exposure 51 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 11 32 1.7 (0.8–3.5) 1.5 (0.7–3.1)
> 0- < =1.136 g 89 491 0.9 (0.6–1.3) 1.1 (0.7–1.7)
0 (Referent) 51 248 1.0 (−-----)
P value for trend 0.33
Anencephaly (N = 82)
Any Exposure 54 523 0.9 (0.6–1.5) 1.1 (0.7–1.9)
No Exposure 28 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 5 32 1.4 (0.5–3.8) 1.1 (0.4–3.1)
> 0- < =1.136 g 49 491 0.9 (0.5–1.4) 1.1 (0.6–1.9)
0 (Referent) 28 248 1.0 (−-----)
P value for trend 0.86
Spina bifida with and without hydrocephalus (N = 69)
Any Exposure 46 523 0.9 (0.6–1.6) 1.2 (0.7–2.2)
No Exposure 23 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 6 32 2.0 (0.8–5.3) 2.0 (0.8–5.4)
> 0- < =1.136 g 40 491 0.9 (0.5–1.5) 1.1 (0.6–2.1)
0 (Referent) 23 248 1.0 (−-----)
P value for trend 0.16
Other CNS Defects (N = 117)
Any Exposure 83 523 1.2 (0.8–1.8) 1.1 (0.7–1.8)
No Exposure 34 248 1.0 (−------)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 2 32 ------b ------b
> 0- < =1.136 g 81 491 1.2 (0.8–1.8) 1.2 (0.7–1.9)
0 (Referent) 34 248 1.0 (−-----)
P value for trend N/A
All Oral Clefts (N = 112)
Any Exposure 81 523 1.2 (0.8–1.9) 1.7 (1.0–2.8)
No Exposure 31 248 1.0 (−-----)
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exposure assessment methods and exposure levels. In par-
ticular, it is possible that the stronger associations ob-
served in our prior cohort study in Cape Cod MA
resulted from higher exposure levels. The average monthly
exposure levels in our prior cohort study ranged from
9.6 × 10− 05 to 131.8 g and the 25th, 50th, 75th and 90th
percentiles were 0.1, 0.6, 2.3 and 6.4 g, respectively [20];
see Table 1 for comparison.
In summary, the results of the present study suggest
that pregnant women with “high” levels of exposure to
PCE-contaminated drinking water (> 40 μg/L) have in-
creased odds of having a child with spina bifida, cleft lip
and hypospadias. These findings are biologically plausible
given evidence of placental transfer of PCE [48]. They also
support the results of several other studies that have ob-
served increased risks of certain birth defects following
prenatal exposure to solvents in occupational and envir-
onmental settings. Even though PCE contamination from
VLAC pipes was remediated many years ago and the
levels are no longer elevated in MA and RI [7, 8], the solv-
ent remains a common contaminant of U.S. drinking
water supplies [1] and so environmental regulations must
be guided by a precautionary perspective that safeguards
pregnant women and their offspring.
Table 3 Frequencies, Odds Ratios and 95% Confidence Intervals for Birth Defects According to Average Monthly PCE Exposure
during Year First Trimester Ended (Continued)
Number of Cases Number of Controls Crude Odds Ratio (95% CI) Multivariablea Odds Ratio (95% CI)
Exposure Categorized by 1980 Action Level
> 1.136 g (> 40μg/L) 6 32 1.5 (0.6–3.9) 2.2 (0.8–6.0)
> 0- < =1.136 g 75 491 1.2 (0.8–1.9) 1.7 (1.0–2.8)
0 (Referent) 31 248 1.0 (−-----)
P value for trend 0.13
Cleft Lip with or without Cleft Palate (N = 59)
Any Exposure 44 523 1.4 (0.8–2.5) 2.1 (1.1–4.0
No Exposure 15 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 5 32 2.6 (0.9–7.6) 3.8 (1.2–12.3)
> 0- < =1.136 g 39 491 1.3 (0.7–2.4) 1.9 (1.0–3.8)
0 (Referent) 15 248 1.0 (−-----)
P value for trend 0.02
Cleft Palate Alone (N = 53)
Any Exposure 37 523 1.1 (0.6–2.0) 1.4 (0.7–2.7)
No Exposure 16 248 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 1 32 ------b ------b
> 0- < =1.136 g 36 491 1.1 (0.6–2.1) 1.4 (0.7–2.8)
0 (Referent) 16 248 1.0 (−-----)
P value for trend N/A
Hypospadias (N = 94)c
Any Exposure 58 266 0.9 (0.5–1.4) 1.3 (0.8–2.2)
No Exposure 36 142 1.0 (−-----)
Exposure Categorized by 1980 Action Level
> 1.136 g (>40μg/L) 3 11 1.1 (0.3–4.1) 2.1 (0.5–8.3)
> 0- < =1.136 g 55 255 0.9 (0.5–1.4) 1.3 (0.8–2.2)
0 (Referent) 36 142 1.0 (−-----)
P value for trend 0.31
aAll adjusted analyses control for state of birth, delivery year. In addition, maternal alcohol use during pregnancy is controlled in the oral cleft analysis and
maternal race is controlled in the hypospadias analysis
bNot calculated
cAnalysis includes only male cases and controls
N/A not applicable
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